|
|
|
|
Astria Therapeutics Inc (NASDAQ: ATXS) |
|
|
|
| |
Astria Therapeutics Inc Accounts Receivables Turnover Ratio from the third quarter 2025 to the third quarter 2024
Quarterly Results, Trends, Rankings, Statistics
Astria Therapeutics Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the third quarter 2025 to a ratio of 0.16, above the company average. This is a clear sign of healthy business climate in the Major Pharmaceutical Preparations industry and improving liquidity at their respective customers, during the third quarter 2025. Astria Therapeutics Inc 's Accounts Receivable average collection period in the Sep 30 2025 quarter, | |